Tuesday, April 09, 2019 4:50:16 PM
Recent ATAI News
- atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit • GlobeNewswire Inc. • 10/15/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:32:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:30:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:30:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:02:03 PM
- atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 11:00:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:23:44 AM
- atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 08/13/2024 11:10:00 AM
- atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT) • GlobeNewswire Inc. • 08/13/2024 11:00:00 AM
- atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference • GlobeNewswire Inc. • 06/26/2024 11:00:17 AM
- atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a • GlobeNewswire Inc. • 06/20/2024 11:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:00:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 12:00:49 PM
- atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference • GlobeNewswire Inc. • 05/31/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 11:10:17 AM
- atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors • GlobeNewswire Inc. • 05/23/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 09:30:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 11:53:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 11:15:45 AM
- atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates • GlobeNewswire Inc. • 05/15/2024 10:59:58 AM
- atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression • GlobeNewswire Inc. • 04/24/2024 11:00:38 AM
- atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology • GlobeNewswire Inc. • 04/17/2024 11:00:01 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM